Abstract

Amphiphilic landscape phage fusion proteins with high affinity and selectivity towards breast cancer MCF-7 (Michigan Cancer Foundation-7) cells self-assemble with polymeric PEG-PE conjugates to form mixed micelles (phage-micelles) capable of cancer cell-targeted delivery of poorly-soluble drugs. While the PEG corona provides the stability and longevity to the micelles, its presence is a potential steric difficulties for the interaction of phage fusion protein with cell surface targets. We attempted to address this problem by controlling the length of the PEG block and the phage fusion protein quantity, selecting the optimal ones to produce a reasonable retention of the targeting affinity and selectivity of the MCF-7-specific phage fusion protein. Three PEG-PE conjugates with different PEG lengths were used to construct phage- and plain-micelles, followed by FACS analysis of the effect of the PEG length on their binding affinity and selectivity towards target MCF-7 cells using either a MCF-7 cell monoculture or a cell co-culture model composed of target cancer MCF-7 cells and non-target, non-cancer C166 cells expressing GFP (Green Fluorescent Protein). Both, the length of PEG and quantity of phage fusion protein had a profound impact on the targetability of the phage-micelles. Phage-micelles prepared with PEG2k-PE achieved a desirable binding affinity and selectivity. Incorporation of a minimal concentration of phage protein, up to 0.5%, produced maximal targeting efficiency towards MCF-7 cells. Overall, phage-micelles with PEG2k-PE and 0.5% of phage protein represent the optimal formulation for targeting towards breast cancer cells.

Highlights

  • Lipophilic compounds account for more than 40% of new drug candidate molecules

  • MCF-7 specific phage fusion protein showed less advantage in tumorcell targeting compared to non-modified plain micelles

  • To investigate the binding selectivity of different micelle formulations towards target MCF-7 cancer cells compared to nontarget, non-cancer cells, we have designed a co-culture assay, in which target cancer MCF-7 cells were co-grown with non-target, non-cancer endothelial cells, C166 cells expressing GFP (C166-GFP)

Read more

Summary

Introduction

Lipophilic compounds account for more than 40% of new drug candidate molecules Despite their potent pharmacological activity, therapeutic application of these molecules is limited due to their poor solubility and low bioavailability. To overcome this limitation, many efforts have been made to develop effective drug delivery systems in order to enhance solubility of hydrophobic drugs [1,2,3,4]. Micellar drug delivery systems substantially increase the bioavailability of poorly-soluble pharmaceuticals and protect them from destructive factors upon parenteral administration [10] Their nanometre-sizes (typically, between 5 and 50 nm) allow micellar drugs to passively target tumor sites via the Enhanced

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call